Cogent Biosciences, Inc. (COGT) Social Stream
COGENT BIOSCIENCES INC (COGT) Price Targets From Analysts
Use the tables below to see what analysts covering COGENT BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-11 | 7 | $31 | $15 | $21.428 | $9.81 | 118.43% |
| 2022-02-08 | 7 | $31 | $14 | $20.571 | $9.81 | 109.69% |
| 2022-03-16 | 7 | $31 | $14 | $20.428 | $9.81 | 108.24% |
| 2022-05-10 | 6 | $23 | $14 | $19 | $9.81 | 93.68% |
| 2022-06-09 | 6 | $23 | $14 | $18.166 | $9.81 | 85.18% |
| 2022-06-17 | 6 | $23 | $15 | $18.333 | $9.81 | 86.88% |
| 2022-07-27 | 7 | $23 | $15 | $17.857 | $9.81 | 82.03% |
| 2022-08-08 | 7 | $23 | $15 | $18.571 | $9.81 | 89.31% |
| 2022-08-09 | 7 | $22 | $15 | $18.428 | $9.81 | 87.85% |
| 2022-11-02 | 5 | $28 | $15 | $20.5 | $9.81 | 108.97% |
| 2022-11-14 | 6 | $28 | $15 | $20.5 | $9.81 | 108.97% |
| 2022-12-12 | 6 | $28 | $15 | $20 | $9.81 | 103.87% |
| 2022-12-14 | 7 | $28 | $18 | $21.857 | $9.81 | 122.8% |
| 2023-02-07 | 7 | $28 | $18 | $22.142 | $9.81 | 125.71% |
| 2023-03-14 | 7 | $28 | $18 | $22.285 | $9.81 | 127.17% |
| 2023-03-27 | 8 | $28 | $18 | $23 | $9.81 | 134.45% |
| 2023-04-25 | 8 | $28 | $18 | $22.875 | $9.81 | 133.18% |
| 2023-04-28 | 9 | $28 | $18 | $22.555 | $9.81 | 129.92% |
| 2023-06-04 | 9 | $28 | $18 | $22.333 | $9.81 | 127.66% |
| 2023-06-05 | 9 | $28 | $18 | $22.111 | $9.81 | 125.39% |
| 2023-07-26 | 9 | $27 | $18 | $22.222 | $9.81 | 126.52% |
| 2023-08-08 | 9 | $27 | $18 | $22 | $9.81 | 124.26% |
| 2023-08-30 | 9 | $27 | $18 | $22.111 | $9.81 | 125.39% |
The Trend in the Analyst Price Target
Over the past 26 months, COGT's average price target has gone up $1.28.
Over the past 44 weeks, COGT's average upside potential has been 79%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-14 | 6 | 28 | 15 | 20.333 | 12.13 | 67.63% |
| 2023-01-05 | 7 | 28 | 18 | 22.142 | 12.00 | 84.52% |
| 2023-03-14 | 7 | 28 | 18 | 22.285 | 12.98 | 71.69% |
| 2023-07-26 | 9 | 27 | 18 | 22.222 | 12.17 | 82.6% |
| 2023-08-09 | 9 | 27 | 18 | 22.111 | 11.83 | 86.91% |
COGT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.11 | 8 | 1 | 0 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
Over the past 16 months, COGT's average broker recommendation rating worsened by 0.11.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, COGENT BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 2127.31% of them.
- In terms of how COGENT BIOSCIENCES INC fares relative to all US stocks, note that its average analyst price target is greater than 731.8% of that group.
- COGENT BIOSCIENCES INC's number of analysts covering the stock is higher than 2317.48% of stocks in the small market cap category.
- COGENT BIOSCIENCES INC's variance in analysts' estimates is lower than -869.06% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, UBX, FIXX, and BTAI are the three stocks most similar to COGENT BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding COGT using the data that counts. Try POWR Ratings for free.